Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
International Journal of Molecular Sciences|February 25, 2023
Novel Molecules in Diabetes Mellitus, Dyslipidemia and Cardiovascular DiseaseCosmin Mihai Vesa, Simona Gabriela BungauInternational Journal of Molecular Sciences|September 14, 2024
Novel Molecules in Diabetes Mellitus, Dyslipidemia and Cardiovascular Disease 2.0Cosmin Mihai Vesa, Simona Gabriela BungăuDiagnostics (Basel, Switzerland)|August 27, 2021
Severe Cardiac and Metabolic Pathology Induced by Steroid Abuse in a Young IndividualAdrian Tirla, Cosmin Mihai Vesa, Simona CavaluInternational Journal of Molecular Sciences|May 25, 2024
Molecular Mechanisms of Metabolic SyndromeCosmin Mihai Vesa, Dana Carmen Zaha, Simona Gabriela BungăuJournal of Nutrition and Metabolism|October 4, 2023
The Crucial Role of Diet Therapy and Selenium on the Evolution of Clinical and Paraclinical Parameters in Patients with Metabolic SyndromeAdrian Marius Danciu, Timea Claudia Ghitea, Alexa Florina Bungau, et al.Healthcare (Basel, Switzerland)|October 16, 2025
Patterns of Psychiatric Comorbidity Among Drug Users: A Prospective Observational Study in a Romanian Psychiatric HospitalAndreea Atena Zaha, Antonia Lucia Comșa, Dana Carmen Zaha, et al.In Vivo (Athens, Greece)|October 31, 2023
The Relationship Between Oxidative Stress, Selenium, and Cumulative Risk in Metabolic SyndromeAdrian Marius Danciu, Timea Claudia Ghitea, Alexa Florina Bungau, et al.Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|April 16, 2025
Unveiling the complexity of neurofibromatosis type 1: Innovations in genetic understanding and clinical management. A narrative reviewAurora Jurca, Simona Pop, Claudia Maria Jurca, et al.Healthcare (Basel, Switzerland)|October 29, 2025
Interrelationship Between Dyslipidemia and Hyperuricemia in Patients with Uncontrolled Type 2 Diabetes: Clinical Implications and a Risk Identification AlgorithmLorena Paduraru, Cosmin Mihai Vesa, Mihaela Simona Popoviciu, et al.International Journal of Molecular Sciences|April 14, 2026
Disproportionality Analysis of Tirzepatide vs. Semaglutide and Liraglutide: System Organ Class-Level Post-Marketing Reporting Patterns in EudraVigilanceRuxandra Cristina Marin, Cosmin Mihai Vesa, Delia Mirela Tit, et al.Pageof 7